NOAEL Studies
Cosmetic Ingredient
Lactoflavin NOAEL Studies
INCI: LACTOFLAVIN
CAS: 83-88-5
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS_DB 5 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS_DB | NOAEL | 400 | mg/kg bw/day | mouse | oral | 3 day | Short Term Toxicity | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
| COSMOS_DB | NOAEL | 25 | mg/kg bw/day | dog | oral | 153 day | Subchronic | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
| COSMOS_DB | NOAEL | 50 | mg/kg bw/day | rat | oral | 104 day | Multigeneration Reproductive | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
| COSMOS_DB | NOAEL | 10 | mg/kg bw/day | rat | oral | NA | Reproductive | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
| COSMOS_DB | NOAEL | 4 | mg/kg bw/day | rat | oral | NA | Reproductive | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
EFSA_OpenFoodTox_EFSA_ReferencePoints.xlsx 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| EFSA_OpenFoodTox_EFSA_ReferencePoints.xlsx | NOAEL | =160 | mg/kg bw/day | Rat | - | 90 days | subchronic | EFSA FEEDAP - 2016 - OutputID 2752 - no adverse effect observed at single/highest dose - Safety and efficacy of vitamin B2 (riboflavin and riboflavin 5'-phosphate ester monosodium salt) produced by Bacillus subtilis for all animal species based on a dossier submitted by DSM - doi:10.2903/j.efsa.2016.4349 |
EFSA_OpenFoodTox_EFSA_ReferenceValues.xlsx 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| EFSA_OpenFoodTox_EFSA_ReferenceValues.xlsx | ADI (group) | <=0.5 | mg/kg bw/day | Consumers | - | - | ADI (group) | EFSA ANS - 2013 - OutputID 2368 - Consumers - Scientific Opinion on the re-evaluation of riboflavin (E 101(i)) and riboflavin-5'-phosphate sodium (E 101(ii)) as food additives. - doi:10.2903/j.efsa.2013.3357 |
| EFSA_OpenFoodTox_EFSA_ReferenceValues.xlsx | ADI (group) | <=0.5 | mg/kg bw/day | Consumers | - | - | ADI (group) | EFSA ANS - 2013 - OutputID 2368 - Consumers - Scientific Opinion on the re-evaluation of riboflavin (E 101(i)) and riboflavin-5'-phosphate sodium (E 101(ii)) as food additives. - doi:10.2903/j.efsa.2013.3357 |
NTP_ICE_acute_oral 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP_ICE_acute_oral | LD50 | >10000 | mg/kg bw | Rat | oral | acute | Rat Acute Oral Toxicity | record_id=acute_oral_10774; row=13345; data_type=In Vivo; mixture=Chemical; chemical_name=Riboflavin; preferred_name=Riboflavin; dtxsid=DTXSID8021777; url_comptox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID8021777; url_cebs=https://doi.org/10.22427/NTP-DATA-DTXSID8021777; source_file=acute_oral.xlsx |
NTP_ICE_endocrine 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP_ICE_endocrine | Model Score | 0 | unitless | - | - | - | ARPathway2016; AR Pathway Model, Antagonist | sheet=Integrated_approaches; excel_row=14100; RecordID=ARPathway2016_1635; DatasetName=ARPathway2016; DTXSID=DTXSID8021777; Assay=AR Pathway Model, Antagonist; Endpoint=Model Score; Response=0; Response_Unit=Unitless; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID8021777; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID8021777 |
ToxValDB_EFSA 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ToxValDB_EFSA | NOAEL | =160 | mg/kg bw/day | Rat | oral | subchronic; 90 days | subchronic | LONG_REF=EFSA FEEDAP (2016). Safety and efficacy of vitamin B2 (riboflavin and riboflavin 5'-phosphate ester monosodium salt) produced by Bacillus subtilis for all animal species based on a dossier submitted by DSM. doi:10.2903/j.efsa.2016.4349.; TITLE=Safety and efficacy of vitamin B2 (riboflavin and riboflavin 5'-phosphate ester monosodium salt) produced by Bacillus subtilis for all animal species based on a dossier submitted by DSM; AUTHOR=EFSA FEEDAP; DOI=doi:10.2903/j.efsa.2016.4349; STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/65201d30e4b0f0a60ddd1165; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://zenodo.org/record/5076033#.Y9fEoXbMI2z; YEAR=2016; ORIGINAL_YEAR=2016; TOXICOLOGICAL_EFFECT=no effects; STUDY_GROUP=EFSA:15622456:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_a7760f6ec2373cd19943476fc58da48d |
ToxValDB_WHO_JECFA_ADI 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ToxValDB_WHO_JECFA_ADI | ADI | <=0.5 | mg/kg | Human | oral | - | Toxicity Value | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/650b03a2e4b0d99f5a8884e5; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://apps.who.int/food-additives-contaminants-jecfa-database/; SUBSOURCE_URL=https://apps.who.int/food-additives-contaminants-jecfa-database/Home/Chemical/4091; YEAR=1981; ORIGINAL_YEAR=1981; STUDY_GROUP=WHO JECFA ADI:15715758:-:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_0044ad27fd21d0d73044197d9289bb88 |
openFDA substances 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | TLM2976OFR | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C17H20N4O6","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"TLM2976OFR"} |
| openFDA substances | FDA UNII substance identifier | TLM2976OFR | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C17H20N4O6","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"TLM2976OFR"} |
| openFDA substances | FDA UNII substance identifier | TLM2976OFR | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C17H20N4O6","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"TLM2976OFR"} |
| openFDA substances | FDA UNII substance identifier | TLM2976OFR | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C17H20N4O6","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"TLM2976OFR"} |